share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Shanahan Karin

SEC announcement ·  Apr 3 06:50
Summary by Futu AI
On April 1, 2024, Karin Shanahan, EVP of Global Product Development & Supply at Bristol-Myers Squibb (BMY), completed a stock transaction involving the company's common stock. Shanahan exercised options to acquire 3,306 shares at no cost and subsequently sold 1,196 shares at a price of $52.99 per share, resulting in a total sale value of $63,376.04. Following these transactions, Shanahan directly holds 5,336 shares of Bristol-Myers Squibb. Additionally, Shanahan has an indirect ownership of 818.59 shares through the BMS Savings and Investment Program.
On April 1, 2024, Karin Shanahan, EVP of Global Product Development & Supply at Bristol-Myers Squibb (BMY), completed a stock transaction involving the company's common stock. Shanahan exercised options to acquire 3,306 shares at no cost and subsequently sold 1,196 shares at a price of $52.99 per share, resulting in a total sale value of $63,376.04. Following these transactions, Shanahan directly holds 5,336 shares of Bristol-Myers Squibb. Additionally, Shanahan has an indirect ownership of 818.59 shares through the BMS Savings and Investment Program.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.